Skip to main content
Figure 7 | Vascular Cell

Figure 7

From: Limitations of the dorsal skinfold window chamber model in evaluating anti-angiogenic therapy during early phase of angiogenesis

Figure 7

Ang-2 and VEGF inhibition in the intradermal assay. Mice were injected intradermally with Caki-2 renal cell carcinoma cells and treated with either the Ang-2 inhibitor (10 mg/kg) or Sunitinib (100 mg/kg) beginning the day prior to tumor cell inoculation. Tumor volume (A, C) and the number of tumor cell induced blood vessels (B, D) were determined at the end of a 7 day period. Bar, mean with SEM (n = 12); line, median (n = 12); **, p < 0.01; ***, p < 0.0001; Mann–Whitney U-Test.

Back to article page